 | • レポートコード：D0804-16402 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、血漿タンパク質治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。血漿タンパク質治療の種類別市場規模（凝固因子、免疫グロブリン、アルブミン、その他）、用途別市場規模（血友病、PID、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Shire (Baxalta)、BPL、Octapharma、CSL、Biotest、Grifols、CBPO、LFB Group、Kedrion、RAAS、Hualan Bio、Kamada ・地域別グローバル市場分析 2015年-2020年 ・血漿タンパク質治療の北米市場（アメリカ、カナダ、メキシコ） ・血漿タンパク質治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・血漿タンパク質治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・血漿タンパク質治療の南米市場（ブラジル、アルゼンチン） ・血漿タンパク質治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：凝固因子、免疫グロブリン、アルブミン、その他 ・用途別分析：血友病、PID、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Plasma Protein Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Plasma Protein Therapeutics sales will be xx in 2020 from Plasma Protein Therapeutics million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Plasma Protein Therapeutics market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Plasma Protein Therapeutics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Plasma Protein Therapeutics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Plasma Protein Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Plasma Protein Therapeutics market has been segmented into:
Coagulation Factor
Immune Globulin
Albumin
Others
By Application, Plasma Protein Therapeutics has been segmented into:
Hemophilia
PID
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Plasma Protein Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Plasma Protein Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Plasma Protein Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Plasma Protein Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Plasma Protein Therapeutics Market Share Analysis
Plasma Protein Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Plasma Protein Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Plasma Protein Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Plasma Protein Therapeutics are:
Shire (Baxalta)
BPL
Octapharma
CSL
Biotest
Grifols
CBPO
LFB Group
Kedrion
RAAS
Hualan Bio
Kamada
1 Plasma Protein Therapeutics Market Overview
1.1 Product Overview and Scope of Plasma Protein Therapeutics
1.2 Classification of Plasma Protein Therapeutics by Type
1.2.1 Global Plasma Protein Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Type in 2019
1.2.3 Coagulation Factor
1.2.4 Immune Globulin
1.2.5 Albumin
1.2.6 Others
1.3 Global Plasma Protein Therapeutics Market by Application
1.3.1 Overview: Global Plasma Protein Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hemophilia
1.3.3 PID
1.3.4 Others
1.4 Global Plasma Protein Therapeutics Market by Regions
1.4.1 Global Plasma Protein Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Plasma Protein Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Plasma Protein Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Plasma Protein Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Plasma Protein Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Plasma Protein Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Plasma Protein Therapeutics Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Plasma Protein Therapeutics Industry Impact
1.5.1 COVID-19 Potential Implications for the Plasma Protein Therapeutics
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Plasma Protein Therapeutics
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Shire (Baxalta)
2.1.1 Shire (Baxalta) Details
2.1.2 Shire (Baxalta) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Shire (Baxalta) SWOT Analysis
2.1.4 Shire (Baxalta) Product and Services
2.1.5 Shire (Baxalta) Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 BPL
2.2.1 BPL Details
2.2.2 BPL Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 BPL SWOT Analysis
2.2.4 BPL Product and Services
2.2.5 BPL Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Octapharma
2.3.1 Octapharma Details
2.3.2 Octapharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Octapharma SWOT Analysis
2.3.4 Octapharma Product and Services
2.3.5 Octapharma Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CSL SWOT Analysis
2.4.4 CSL Product and Services
2.4.5 CSL Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biotest SWOT Analysis
2.5.4 Biotest Product and Services
2.5.5 Biotest Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Grifols
2.6.1 Grifols Details
2.6.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Grifols SWOT Analysis
2.6.4 Grifols Product and Services
2.6.5 Grifols Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 CBPO
2.7.1 CBPO Details
2.7.2 CBPO Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 CBPO SWOT Analysis
2.7.4 CBPO Product and Services
2.7.5 CBPO Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 LFB Group
2.8.1 LFB Group Details
2.8.2 LFB Group Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 LFB Group SWOT Analysis
2.8.4 LFB Group Product and Services
2.8.5 LFB Group Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Kedrion
2.9.1 Kedrion Details
2.9.2 Kedrion Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Kedrion SWOT Analysis
2.9.4 Kedrion Product and Services
2.9.5 Kedrion Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 RAAS
2.10.1 RAAS Details
2.10.2 RAAS Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 RAAS SWOT Analysis
2.10.4 RAAS Product and Services
2.10.5 RAAS Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Hualan Bio SWOT Analysis
2.11.4 Hualan Bio Product and Services
2.11.5 Hualan Bio Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Kamada
2.12.1 Kamada Details
2.12.2 Kamada Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Kamada SWOT Analysis
2.12.4 Kamada Product and Services
2.12.5 Kamada Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Plasma Protein Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Plasma Protein Therapeutics Players Market Share
3.2.2 Top 10 Plasma Protein Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Plasma Protein Therapeutics Revenue and Market Share by Regions
4.2 North America Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Plasma Protein Therapeutics Revenue by Countries
5.1 North America Plasma Protein Therapeutics Revenue by Countries (2015-2020)
5.2 USA Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Plasma Protein Therapeutics Revenue by Countries
6.1 Europe Plasma Protein Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Plasma Protein Therapeutics Revenue by Countries
7.1 Asia-Pacific Plasma Protein Therapeutics Revenue by Countries (2015-2020)
7.2 China Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Plasma Protein Therapeutics Revenue by Countries
8.1 South America Plasma Protein Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Plasma Protein Therapeutics by Countries
9.1 Middle East & Africa Plasma Protein Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Plasma Protein Therapeutics Market Forecast by Type (2019-2024)
10.3 Coagulation Factor Revenue Growth Rate (2015-2025)
10.4 Immune Globulin Revenue Growth Rate (2015-2025)
10.5 Albumin Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Plasma Protein Therapeutics Market Segment by Application
11.1 Global Plasma Protein Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Plasma Protein Therapeutics Market Forecast by Application (2019-2024)
11.3 Hemophilia Revenue Growth (2015-2020)
11.4 PID Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Plasma Protein Therapeutics Market Size Forecast (2021-2025)
12.1 Global Plasma Protein Therapeutics Market Size Forecast (2021-2025)
12.2 Global Plasma Protein Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Plasma Protein Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Plasma Protein Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Plasma Protein Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Plasma Protein Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Plasma Protein Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Plasma Protein Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Plasma Protein Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Plasma Protein Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Plasma Protein Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Plasma Protein Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Shire (Baxalta) Corporate Information, Location and Competitors
Table 7. Shire (Baxalta) Plasma Protein Therapeutics Major Business
Table 8. Shire (Baxalta) Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 9. Shire (Baxalta) SWOT Analysis
Table 10. Shire (Baxalta) Plasma Protein Therapeutics Product and Solutions
Table 11. Shire (Baxalta) Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. BPL Corporate Information, Location and Competitors
Table 13. BPL Plasma Protein Therapeutics Major Business
Table 14. BPL Plasma Protein Therapeutics Total Revenue (USD Million) (2018-2019)
Table 15. BPL SWOT Analysis
Table 16. BPL Plasma Protein Therapeutics Product and Solutions
Table 17. BPL Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Octapharma Corporate Information, Location and Competitors
Table 19. Octapharma Plasma Protein Therapeutics Major Business
Table 20. Octapharma Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 21. Octapharma SWOT Analysis
Table 22. Octapharma Plasma Protein Therapeutics Product and Solutions
Table 23. Octapharma Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. CSL Corporate Information, Location and Competitors
Table 25. CSL Plasma Protein Therapeutics Major Business
Table 26. CSL Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 27. CSL SWOT Analysis
Table 28. CSL Plasma Protein Therapeutics Product and Solutions
Table 29. CSL Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Biotest Corporate Information, Location and Competitors
Table 31. Biotest Plasma Protein Therapeutics Major Business
Table 32. Biotest Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 33. Biotest SWOT Analysis
Table 34. Biotest Plasma Protein Therapeutics Product and Solutions
Table 35. Biotest Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Grifols Corporate Information, Location and Competitors
Table 37. Grifols Plasma Protein Therapeutics Major Business
Table 38. Grifols Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 39. Grifols SWOT Analysis
Table 40. Grifols Plasma Protein Therapeutics Product and Solutions
Table 41. Grifols Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. CBPO Corporate Information, Location and Competitors
Table 43. CBPO Plasma Protein Therapeutics Major Business
Table 44. CBPO Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 45. CBPO SWOT Analysis
Table 46. CBPO Plasma Protein Therapeutics Product and Solutions
Table 47. CBPO Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. LFB Group Corporate Information, Location and Competitors
Table 49. LFB Group Plasma Protein Therapeutics Major Business
Table 50. LFB Group Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 51. LFB Group SWOT Analysis
Table 52. LFB Group Plasma Protein Therapeutics Product and Solutions
Table 53. LFB Group Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Kedrion Corporate Information, Location and Competitors
Table 55. Kedrion Plasma Protein Therapeutics Major Business
Table 56. Kedrion Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 57. Kedrion SWOT Analysis
Table 58. Kedrion Plasma Protein Therapeutics Product and Solutions
Table 59. Kedrion Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. RAAS Corporate Information, Location and Competitors
Table 61. RAAS Plasma Protein Therapeutics Major Business
Table 62. RAAS Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 63. RAAS SWOT Analysis
Table 64. RAAS Plasma Protein Therapeutics Product and Solutions
Table 65. RAAS Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Hualan Bio Corporate Information, Location and Competitors
Table 67. Hualan Bio Plasma Protein Therapeutics Major Business
Table 68. Hualan Bio Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 69. Hualan Bio SWOT Analysis
Table 70. Hualan Bio Plasma Protein Therapeutics Product and Solutions
Table 71. Hualan Bio Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Kamada Corporate Information, Location and Competitors
Table 73. Kamada Plasma Protein Therapeutics Major Business
Table 74. Kamada Plasma Protein Therapeutics Total Revenue (USD Million) (2017-2018)
Table 75. Kamada SWOT Analysis
Table 76. Kamada Plasma Protein Therapeutics Product and Solutions
Table 77. Kamada Plasma Protein Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Plasma Protein Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 79. Global Plasma Protein Therapeutics Revenue Share by Players (2015-2020)
Table 80. Global Plasma Protein Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Plasma Protein Therapeutics Revenue Market Share by Regions (2015-2020)
Table 82. North America Plasma Protein Therapeutics Revenue by Countries (2015-2020)
Table 83. North America Plasma Protein Therapeutics Revenue Market Share by Countries (2015-2020)
Table 84. Europe Plasma Protein Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Plasma Protein Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Plasma Protein Therapeutics Revenue by Countries (2015-2020)
Table 87. South America Plasma Protein Therapeutics Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Plasma Protein Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Countries (2015-2020)
Table 90. Global Plasma Protein Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 91. Global Plasma Protein Therapeutics Revenue Share by Type (2015-2020)
Table 92. Global Plasma Protein Therapeutics Revenue Forecast by Type (2021-2025)
Table 93. Global Plasma Protein Therapeutics Revenue by Application (2015-2020)
Table 94. Global Plasma Protein Therapeutics Revenue Share by Application (2015-2020)
Table 95. Global Plasma Protein Therapeutics Revenue Forecast by Application (2021-2025)
Table 96. Global Plasma Protein Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Plasma Protein Therapeutics Picture
Figure 2. Global Plasma Protein Therapeutics Revenue Market Share by Type in 2019
Figure 3. Coagulation Factor Picture
Figure 4. Immune Globulin Picture
Figure 5. Albumin Picture
Figure 6. Others Picture
Figure 7. Plasma Protein Therapeutics Revenue Market Share by Application in 2019
Figure 8. Hemophilia Picture
Figure 9. PID Picture
Figure 10. Others Picture
Figure 11. Global Plasma Protein Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Plasma Protein Therapeutics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Plasma Protein Therapeutics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Plasma Protein Therapeutics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Plasma Protein Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Plasma Protein Therapeutics Revenue Market Share by Regions in 2018
Figure 25. North America Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. South America Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. North America Plasma Protein Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Plasma Protein Therapeutics Revenue Market Share by Countries in 2019
Figure 32. USA Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Plasma Protein Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Plasma Protein Therapeutics Revenue Market Share by Countries in 2019
Figure 37. Germany Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. UK Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. France Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Plasma Protein Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Plasma Protein Therapeutics Revenue Market Share by Countries in 2019
Figure 44. China Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. India Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. South America Plasma Protein Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Plasma Protein Therapeutics Revenue Market Share by Countries in 2019
Figure 51. Brazil Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Plasma Protein Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. Global Plasma Protein Therapeutics Revenue Share by Type (2015-2020)
Figure 60. Global Plasma Protein Therapeutics Revenue Share by Type in 2019
Figure 61. Global Plasma Protein Therapeutics Market Share Forecast by Type (2021-2025)
Figure 62. Global Coagulation Factor Revenue Growth Rate (2015-2020)
Figure 63. Global Immune Globulin Revenue Growth Rate (2015-2020)
Figure 64. Global Albumin Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Plasma Protein Therapeutics Revenue Share by Application (2015-2020)
Figure 67. Global Plasma Protein Therapeutics Revenue Share by Application in 2019
Figure 68. Global Plasma Protein Therapeutics Market Share Forecast by Application (2021-2025)
Figure 69. Global Hemophilia Revenue Growth Rate (2015-2020)
Figure 70. Global PID Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Plasma Protein Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Plasma Protein Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Europe Plasma Protein Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Plasma Protein Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. South America Plasma Protein Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Plasma Protein Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
血漿タンパク質結合アッセイの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Plasma Protein Binding Assay market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plasma Protein B…- 血漿由来ヒト血清アルブミン試験の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Plasma-derived Human Serum Albumin Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plasm…
- 血漿由来薬物の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Plasma Derived Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plasma Derived Drugs mar…
- プラズマ手術の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Plasma Surgery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 医療用コールドプラズマの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Medical Cold Plasma market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Medical Cold Plasma marke…